Smilow Center for Translational Research

Smilow Center for Translational Research
Name	Smilow Center for Translational Research
Established	2010
Parent	Perelman School of Medicine at the University of Pennsylvania
Location	Philadelphia, Pennsylvania
Affiliation	University of Pennsylvania Health System
Director	Kathryn E. Wellen

Smilow Center for Translational Research. The Smilow Center for Translational Research is a premier biomedical research facility dedicated to accelerating the translation of scientific discoveries into new therapies and diagnostic tools for patients. It is a core component of the Perelman School of Medicine at the University of Pennsylvania and is integrally linked with the University of Pennsylvania Health System. The center fosters a collaborative environment where basic scientists and clinical investigators work side-by-side to address complex human diseases.

History and establishment

The center was established in 2010 through a transformative philanthropic gift from Joel Smilow, a noted alumnus of the University of Pennsylvania and former CEO of Playtex Products Inc.. This gift was part of a broader initiative to expand the university's capabilities in translational medicine and solidify its leadership in the life sciences. The construction of the state-of-the-art facility was a cornerstone of the Penn Medicine strategic plan to create contiguous research space adjacent to the Hospital of the University of Pennsylvania. Its opening marked a significant milestone in the evolution of the Pennsylvania biomedical corridor, enhancing the physical and intellectual infrastructure for interdisciplinary research. The center was designed to break down traditional barriers between laboratory science and clinical practice, embodying the principles of the National Institutes of Health's Clinical and Translational Science Awards consortium.

Research focus and programs

The center's research portfolio is strategically focused on several high-impact areas of human disease, with particular strengths in oncology, immunology, neuroscience, and cardiovascular disease. Its programs are designed to move discoveries from "bench to bedside," encompassing early-stage drug discovery, biomarker development, and early-phase clinical trials. Key initiatives often involve advanced technologies such as genomics, proteomics, and cell therapy. Researchers at the center are deeply involved in pioneering work on CAR T-cell therapy, a field where University of Pennsylvania scientists like Carl June have achieved global recognition. Other major programs investigate the metabolic basis of cancer, neurodegenerative disorders like Alzheimer's disease, and autoimmune conditions, leveraging core facilities for high-throughput screening and data science.

Facilities and resources

Housed in a modern 13-story building on the Perelman School of Medicine at the University of Pennsylvania campus, the center provides over 500,000 square feet of dedicated laboratory and administrative space. The facility is architecturally designed to promote collaboration, with open lab layouts, shared equipment cores, and communal areas that encourage interaction among investigators from different disciplines. Key shared resources include advanced flow cytometry suites, confocal microscopy imaging centers, a GMP-compliant cell manufacturing facility critical for cell therapy trials, and a robust biorepository. The building's proximity to the Hospital of the University of Pennsylvania, the Abramson Cancer Center, and the Children's Hospital of Philadelphia facilitates seamless access to patient populations and clinical expertise.

Key personnel and leadership

The center is led by Director Kathryn E. Wellen, a prominent researcher in cancer metabolism and epigenetics. Scientific direction is further provided by the leadership of the Perelman School of Medicine at the University of Pennsylvania, including the Dean and the Vice Dean for Research. The center houses the laboratories of numerous distinguished investigators and Howard Hughes Medical Institute scholars. Notable faculty whose work is centered there include immunologist E. John Wherry, cancer biologist Celeste Simon, and neuroscientist Virginia M.-Y. Lee. This concentration of expertise creates a dynamic intellectual environment that attracts postdoctoral fellows and graduate students from programs like the Biomedical Graduate Studies at the university.

Collaborations and partnerships

The center operates as a nexus for extensive local, national, and international partnerships. Within the University of Pennsylvania ecosystem, it maintains strong ties with the Abramson Cancer Center, the Institute for Immunology, and the Mahoney Institute of Neurological Sciences. It is a central hub for the Penn Clinical and Translational Science Institute, funded by the National Center for Advancing Translational Sciences. Externally, the center collaborates with pharmaceutical and biotechnology companies, including Novartis and GlaxoSmithKline, on therapeutic development. It also engages in multi-institutional consortia funded by agencies such as the National Cancer Institute and the Michael J. Fox Foundation, sharing resources and data to accelerate research progress.

Impact and notable achievements

Research conducted at the center has had a profound impact on modern medicine, most notably through the development and clinical implementation of Kymriah, the first FDA-approved CAR T-cell therapy for leukemia. This breakthrough emerged directly from collaborative work within its laboratories and clinical units. The center's investigators have contributed seminal discoveries in understanding immune checkpoint pathways, the role of metabolism in tumor growth, and the protein pathology underlying Parkinson's disease. Its infrastructure has been instrumental in rapidly launching clinical trials for novel therapies across a spectrum of conditions. The center's model of integrated translational science continues to attract major funding from the National Institutes of Health, the Department of Defense, and private foundations, cementing its role as a global leader in advancing human health.

Category:Medical and health organizations based in Pennsylvania Category:University of Pennsylvania Category:Medical research institutes in the United States